Gwenaelle CREFF

Dr. Gwenaelle CREFF

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 October 2023 in Ear & Hearing
Verified
Journal Article
Closed access
GCGwenaelle CREFF
Gwenaelle CREFF
CLCassandre Lambert
Cassandre Lambert
PCPaul Coudert
Paul Coudert
VPVincent Pean
Vincent Pean
SLStephane Laurent
Stephane Laurent
BGBenoit Godey
Benoit Godey
Objectives: While cochlear implants (CIs) have provided benefits for speech recognition in quiet for subjects with severe-to-profound hearing loss, speech recognition in noise remains challenging. A body of evidence suggests that reducing frequency-to-place mismatch may positively affect speech perception. Thus, a fitting method based on a tonotopic map may improve speech perception results in quiet and noise. The aim of our study was to assess the impact of a tonotopic map on speech perception in noise and quiet in new CI users. Design: A prospective, randomized, double-blind, two-period cross-over study in 26 new CI users was performed over a 6-month period. New CI users older than 18 years with bilateral severe-to-profound sensorineural hearing loss or complete hearing loss for less than 5 years were selected in the University Hospital Centre of Rennes in France. An anatomical tonotopic map was created using postoperative flat-panel computed tomography and a reconstruction software based on the Greenwood function. Each participant was randomized to receive a conventional map followed by a tonotopic map or vice versa. Each setting was maintained for 6 weeks, at the end of which participants performed speech perception tasks. The primary outcome measure was speech recognition in noise. Participants were allocated to sequences by block randomization of size two with a ratio 1:1 (CONSORT Guidelines). Participants and those assessing the outcomes were blinded to the intervention. Results: Thirteen participants were randomized to each sequence. Two of the 26 participants recruited (one in each sequence) had to be excluded due to the COVID-19 pandemic. Twenty-four participants were analyzed. Speech recognition in noise was significantly better with the tonotopic fitting at all signal-to-noise ratio (SNR) levels tested [SNR = +9 dB, p = 0.002, mean effect (ME) = 12.1%, 95% confidence interval (95% CI) = 4.9 to 19.2, standardized effect size (SES) = 0.71; SNR = +6 dB, p < 0.001, ME = 16.3%, 95% CI = 9.8 to 22.7, SES = 1.07; SNR = +3 dB, p < 0.001 ME = 13.8%, 95% CI = 6.9 to 20.6, SES = 0.84; SNR = 0 dB, p = 0.003, ME = 10.8%, 95% CI = 4.1 to 17.6, SES = 0.68]. Neither period nor interaction effects were observed for any signal level. Speech recognition in quiet (p = 0.66) and tonal audiometry (p = 0.203) did not significantly differ between the two settings. 92% of the participants kept the tonotopy-based map after the study period. No correlation was found between speech-in-noise perception and age, duration of hearing deprivation, angular insertion depth, or position or width of the frequency filters allocated to the electrodes. Conclusion: For new CI users, tonotopic fitting appears to be more efficient than the default frequency fitting because it allows for better speech recognition in noise without compromising understanding in quiet.

12 August 2021 in Journal of Cancer Survivorship
Verified
Journal Article
Closed access
PDF file
GCGwenaelle CREFF
Gwenaelle CREFF
FJF. Jegoux
F. Jegoux
MBMarc Karim Bendiane
Marc Karim Bendiane
EBE. Babin
E. Babin
ILIdlir Licaj
Idlir Licaj

12 February 2025 in Biology
Verified
Journal Article
Open access
PDF file
HJHadrien Jean
Hadrien Jean
NWNicolas Wallaert
Nicolas Wallaert
ADAntoine Dreumont
Antoine Dreumont
GCGwenaelle CREFF
Gwenaelle CREFF
BGBenoit Godey
Benoit Godey
NPNihaad Paraouty
Nihaad Paraouty
In addition to pure-tone audiometry tests and electrophysiological tests, a comprehensive hearing evaluation includes assessing a subject’s ability to understand speech in quiet and in noise. In fact, speech audiometry tests are commonly used in clinical practice; however, they are time-consuming as they require manual scoring by a hearing professional. To address this issue, we developed an automated speech recognition (ASR) system for scoring subject responses at the phonetic level. The ASR was built using a deep neural network and trained with pre-recorded French speech materials: Lafon’s cochlear lists and Dodelé logatoms. Next, we tested the performance and reliability of the ASR in clinical settings with both normal-hearing and hearing-impaired listeners. Our findings indicate that the ASR’s performance is statistically similar to manual scoring by expert hearing professionals, both in quiet and in noisy conditions. Moreover, the test–retest reliability of the automated scoring closely matches that of manual scoring. Together, our results validate the use of this deep neural network in both clinical and research contexts for conducting speech audiometry tests in quiet and in noise.

27 November 2021 in Supportive Care in Cancer
Verified
Journal Article
Closed access
PDF file
GCGwenaelle CREFF
Gwenaelle CREFF
FJFranck Jegoux
Franck Jegoux
MBMarc Karim Bendiane
Marc Karim Bendiane
EBEmmanuel Babin
Emmanuel Babin
ILIdlir Licaj
Idlir Licaj

9 December 2021 in Journal of Nuclear Medicine
Verified
Journal Article
Open access
PDF file
GCGwenaelle CREFF
Gwenaelle CREFF
FJFranck Jegoux
Franck Jegoux
XPXavier Palard
Xavier Palard
ADAdrien Depeursinge
Adrien Depeursinge
RARonan Abgral
Ronan Abgral
JCJoel Castelli
Joel Castelli
Rationale: The aims of this multicenter study were to identify clinical and preoperative PET/CT parameters predicting Overall Survival (OS) and Distant Metastasis Free Survival(DMFS) from a cohort of Head and Neck Squamous Cell Carcinoma (HNSCC) patients treated with surgery, to generate a prognostic model of OS and DMFS and to validate this prognostic model with an independent cohort. Materials and Methods: A total of 382 consecutive HNSCC patients divided into training (n = 318) and validation cohorts (n = 64) were retrospectively included. The following PET/CT parameters were analyzed: clinical parameters, SUVmax, SUVMean, Metabolic Tumor Volume (MTV), Total Lesion Glycolysis (TLG) and distance parameters for the primary tumor and lymph nodes defined by two segmentation methods (relative SUVmax threshold and absolute SUV threshold). Cox analyses were performed for OS and DMFS in the training cohort. The c-index was used to identify highly prognostic parameters. These prognostic parameters were externally tested in the validation cohort. Results: In multivariable analysis, the significant parameters for OS were T stage and Nodal-MTV, achieving a c-index of 0.64 (p<0.001). For DMFS, the significant parameters were T stage, Nodal-MTV and maximal tumor-node distance, with a c-index of 0.76 (p<0.001). These combinations of parameters were externally validated, achieving c-indices of 0.63 (p<0.001) and 0.71 (p<0.001) for OS and DMFS, respectively. Conclusion: The Nodal MTV associated with maximal distance between the primary tumor and the lymph node was significantly correlated with the risk of DMFS. Moreover, this parameter in addition to clinical parameters was associated with higher risk of death. These prognostic factors may be used to tailor individualized treatment.

11 October 2024 in European Archives of Oto-Rhino-Laryngology
Verified
Journal Article
Closed access
PDF file
LCLambert Cassandre
Lambert Cassandre
GCGwenaelle CREFF
Gwenaelle CREFF
CPCoudert Paul
Coudert Paul
BNBernard Le Liboux Nicolas
Bernard Le Liboux Nicolas
CMChauvel Marin
Chauvel Marin
GBGodey Benoit
Godey Benoit